Adicet Bio(us:ACET)
0.8832
-2.95%
Updated on 2024-12-23
Open:0.9100
Close:0.8832
High:0.9100
Low:0.8600
Pre Close:0.9100
Volume:385919.00
Amount:341595.22
Turnover:0.47%
Shares:82.40M
MarketCap:72.78M
About Adicet Bio Company
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Company Name: Adicet Bio
Company Address: 131 Dartmouth Street,3rd floor
Employees: 143
Fiscar Year: 12-31
IPO Date: 2018-01-26
Website: http://www.adicetbio.com
CIK: 1720580
View all SEC Filings
About
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Address:131 Dartmouth Street,3rd floor
Website:http://www.adicetbio.com
Market Movers